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ABSTRACT: 
 
The purpose of this study was to determine if the parents of children with autism sought 
biomedical interventions (dietary supplements and special diets) following the positive 
diagnosis of their child. Approval  was obtained from the Ohio State University (OSU) 
Institutional Review Board. Names and phone numbers of children who had a positive 
diagnosis for an Autism Spectrum disorder, including classic autism, Asperger‟s, and 
Persuasive Developmental Disability- Not Otherwise Specified (PDD-NOS) were 
obtained from three OSU diagnostic clinics where these patients had been seen over the 
past 1-25 months.  Fifty-five  families were identified from the database and contacted by 
phone regarding  biomedical interventions explored  since diagnosis. Of these 55, 21 
were successfully interviewed, 2 opted not to be interviewed, 20 were left messages and a 
researcher contact phone number, and 13 had disconnected lines. Of the 21 who 
responded, 12 (57%) used a dietary supplement. Of these 12, 5 used a multivitamin only, 
and 7 used one or more of the following: fish oil, folic acid and vitamin B-12 (pill, 
injection and topical crème), Co-enzyme Q-10, riboflavin, vitamin A, calcium, vitamin 
D, probiotics, magnesium, and fiber.  Number of supplements used was compared with 
months since diagnosis.  Of these same 21 parent respondents, 8 (38%) have tried special 
diets, 6 tried the Gluten Free Casein Free diet (GFCF), and 4 are still following it.  
Sixteen respondents consulted with practitioners (allopathic or alternative); three with a 
registered dietitian, three  with a pediatrician , four nonconventional sources such as a 
Defeat Autism Now Doctor and New Hope Detoxification Doctor , three with “other 
sources”  (a special diet from Helping Hands Education and Therapy Center and a food 
coach). Other resources consulted included  the internet (61%). Educational Intervention 
plans include the development of Nutrition Interventions and Therapies for Autism  
(NITA) as a service to the ever-growing autism community.    
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Problem Statement 
 
For decades, autism was believed to occur in 4 to 5 per 10,000 children (CDC). However, 
in 2007, CDC‟s Autism and Developmental Disabilities Monitoring found that 1 in 150 eight- 
year-old children have an autism spectrum disorder (ASD). This data was taken from many areas 
across the United States and is a national problem. This study takes place through the Nisonger 
Center at Ohio State University, and over the last year 90-95% of the children referred to the 
Nisonger Autism center were diagnosed with a type of ASD. 
Autism is often referred to as ASD because there are different types that tend to fall onto 
a spectrum of levels of functioning. Yale medical center defines a few of these syndromes on the 
spectrum. In Asperger‟s syndrome (AS), patients have deficits in social interaction and unusual 
response to environment but differ from classical autism because cognitive and communicative 
skills are in a near normal range. Another syndrome on the spectrum is Pervasive Developmental 
Disorder not otherwise specified (PDD-NOS). This falls in a “subthreshold” category and no 
specific guidelines are provided. Deficits in peer relations and unusual sensitivities exist, however 
social skills in a normal range. In childhood disintegrative disorder (CDD) children develop 
normally then after a prolonged period (2 to 4 years old) begin to show symptoms of autism (Yale 
School of Medicine, 2008). In terms of level of functioning measures, a study in the Journal of 
the American Academy of Child & Adolescent Psychiatry discovered that children with PDD-
NOS had scores that were between those of the children with autism and those of the children 
with AS (Walker, 2004). 
One study states “Understandably, few disorders can pose a greater threat to the well-
being of families than autism” (Seltzer, Krauss, Orsmond, & Vestal, 2001).  Having a child be 
diagnosed with autism can be an extremely difficult time for parents. Studies have found parents 
become stressed, depressed and sometimes even angry. One stressor described in described in 
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“Living in a World of Our Own: The Experience of Parents Who Have a Child with Autism” is 
the intense treatment that requires a combination of strategies. Another stressor from that article 
is that parents must do all they can. Parents feel they must try anything and everything to help 
their child develop to his or her full potential (Woodgate et al, 2008). One of these strategies 
parents can try is nutritional interventions that include changes in diet and nutritional 
supplements. A survey on supplemental interventions found that parents on average used seven 
supplements at a time (Smith, 2000). One parent even uses fourty seven different supplements 
(Green, 2006). 
These nutritional interventions are referred to as Biologically-based therapies and 
Biomedical therapies interchangeably. These nutritional modifications seek to ameliorate 
symptoms that children that have autism often face such as chronic constipation, diarrhea, 
abdominal pain and GERD. These gastrointestinal symptoms may lead to “tantrums” from the 
child as a way to express his or her discomfort. These biomedical therapies include a gluten free- 
casein free diet because gluten and casein can be hard to digest. Anti-fungals are used to detoxify 
the bowel. Vitamin B-6 and magnesium and Omega-3 are used to treat nutrient defiencies. 
Vitamin b-12, folic acid, dimethylglycine and trymethylglycine are used to treat metabolic 
abnormalities. This study is based on the problem that these special diets and nutritional 
supplements are being used as interventions and therapies for children with ASD without proven 
safety and efficacy.   
 
Literature Review  
 
One common nutritional intervention is a Gluten-Free, Casein-Free (GFCF) diet. It is 
theorized that if a child cannot properly digest gluten and casein, the proteins cause an opioid-like 
effects on the central nervous system. However, what most parents probably do not know is there 
has been a lack of evidence-based research conducted with this diet. The most well-designed 
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research to date was done in 2002 by Knivsberg, Reichelt et all. This trial was small and included 
only 20 subjects, 10 in the treatment group 10 in the placebo group.  The trial lasted 12 months 
and the results were measured using the Danish instrument for measuring autistic traits.  The 
results were positive; social contact increased in 10 of the children and ritualized behaviors 
decreased in 8. While there is this one positive clinical trial for the GFCF diet, most of the 
evidence is anecdotal.  A simple change in diet may seem safe, but it does have its risks. A study 
that was recently published in Journal of Autism and Developmental Disorders, finds that bone 
densities in 5 and 6 year old boys with autism were significantly thinner than the control group of 
boys without autism. This difference increases by age 6 and 7. The researchers hypothesized that 
this was due to a lack of variation in the boys‟ diet, lack of vitamin D, digestive problems and 
diets that exclude casein (Hediger, 2008). Dairy products that are excluded from a CFGF diet are 
a great source of calcium and vitamin D. 
 Dysbiosis is believed to be another cause of GI discomfort. A study presented at a 
“Defeat Autism Now” conference showed that out of 80 children with ASD and GI symptoms, 
61% had abnormal gram negative endotoxin- producing bacteria, 55% had overgrowth of Staph 
aureus and 95% had an overgrowth of Escherichia coli (Rosseneu, 2003). However this study 
found no abnormal amounts to yeast noted. Despite a lack of evidence for presence of yeast, 
many children are being treated with antifungal as part of a bowel detoxification.  Many 
antifungal medications are known to cause a “wide range of liver injury from a mild 
hepatocellular-cholestatic injury pattern to acute/subacute liver failure” (Perveze et al, 2006). 
  Many biomedical treatments address nutrient deficiency. A popular nutrient deficiency 
of current research is a combination of vitamin B6 and Magnesium. Out of the four studies found 
with treatments using the vitamin B6 and Magnesium combo, three showed no effects and one 
showed significant results (Kuriyama, 2002; Tolbert, 1993; Findling, 1997). Mousain-Bosc et al 
did a study with 33 children with PDD on 6 mg/kg/day Mg and .6 mg/kg/day Vit B6 for 8 
months. 60% of the subjects improved in social interaction, communication and stereotyped 
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behavior. The potential risks with this treatment is that high doses of B6 can cause nerve damage 
and high doses of magnesium can cause reduced heart rate and weakened reflexes (Herbert et al, 
2002). 
Supplementing omega-3 is another treatment aimed at treating nutritional deficiency. The 
research with this supplement is contradictory. Two studies show significant improvement in 
behavior (Patrick et al, 2005 and Amminger et al, 2007); however the latest study, presented in 
2008 at the Pediatric Academic Societies annual meeting shows no improvement. The potential 
risk here is that fish oil is an anticoagulant which can lead to problems with surgery and large 
cuts. 
Melatonin supplementation has been suggested to help children with ASD sleep. A 
randomized controlled trial showed significant reduction in sleep latency and increased sleep time 
(Garstang et al, 2006). However, this is also possibly unsafe in children because of its affects on 
gonadal development.   
Dimethylglycine (DMG) and Trimethylgylcine anhydrous (TMG) is used to treat 
metabolic abnormalities. A study by James et al. shows that children with autism have a 
metabolic imbalance when compared to the control group. This imbalance is consistent with 
“impaired capacity for methylation and increased oxidative stress “(James et al). DMG is 
involved in the methylation pathway and adding DMG to a child‟s diet would help normalize this 
balance. A double blind, placebo controlled study done in 2001 showed no difference in behavior 
between the placebo and DMG groups. TMG and DMG can be used to help Vitamin B12 
deficiencies but it is too early to tell effectiveness. No studies to date have been done on the 
safety of TMG and DMG. 
Vitamin B-12 and Folic acid are recommended for children with autism. However, even 
something as harmless as vitamin supplements can be potentially unsafe for children. A case 
study was done on a three year old boy with ASD who was hospitalized with symptoms of 
vomiting ceghalgias, fever and cutaneus abnormalities. These symptoms were due to 
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hypercalcemia that was caused by the biomedical treatment the boy was on for autism that 
included 100 000UI/d during three months and then 150 000UI/d the three following months of 
vitamin A (Kimmoun et al, 2007). 
To add to the risk of these interventions, supplements are not regulated as drugs by the 
FDA, they are regulated as food. Under the Dietary Supplement Health and Education Act of 
1994 (DSHEA), “the dietary supplement manufacturer is responsible for ensuring that a dietary 
supplement is safe before it is marketed” (FDA, 1994). The FDA does have some responsibilities 
after the drug is on the market. These are to take action against unsafe dietary product and make 
sure product information is truthful. Generally, manufacturers do not need to register their 
products with FDA nor get FDA approval before producing or selling dietary supplements.
 
  
According to Herbert et al, “families are often persuaded to try methods that are highly 
unorthodox and scientifically suspect.”  Even when well designed studies have been done, the 
results tend to be contradictory. Many treatments also seem to carry risks, and even though most 
of these biomedical treatments can be bought over the counter, they aren‟t even regulated. Add in 
the other stressors a parent of a child with autism faces and it is easy to see how a parent could 
become overwhelmed. To add to the stress on the parents, children with ASD are very picky 
eaters and resisted trying new foods (Lockner et al, 2008). It is challenging for parents to get 
these picky eaters to eat an altered diet like the gluten free casein free diet. Despite these 
stressors, it is very exciting that there are many possible treatments out there for some of the 
symptoms of autism. And with parents “try anything they can” attitude, it is easy to see why these 
treatments are popular.   
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Research Questions 
 
1) Since their child‟s diagnosis with ASD at Nisonger center, have these parents 
investigated biomedical treatments? Have the parents implemented any of 
these treatments?  
2) Which biomedical treatments have they used? 
3) What sources of information did the parents use? 
a. Ho: Those who do pursue these treatments have not consulted with a 
registered dietitian. 
  
Methods 
 
The sample population comprised of the 55 families of children who have been 
diagnosed at Ohio State University‟s Nisonger center from October 1, 2007 to September 30, 
2008. The inclusion factor is the children must have had a positive diagnosis of autism on the 
spectrum according to DSM 4 criteria.  
This study is a combination of a retrospective look at the charts of the children who have 
visited Nisonger‟s Autism lab and a prospective telephone survey with the parents of these 
children. The retrospective data that was collected from the chart include date of diagnosis, 
demographics and information about the family. Telephone segment queried the parents 
regarding their consideration and implementation of special diets or dietary or herbal supplements 
as well as where they received information on these nutritional alterations. A review of the 
literature has found no questionnaire that has been tested for validity or reliability.  Therefore the 
telephone script has been written and revised with a qualitative researcher and reviewed for 
content validity. A phone interview is being used instead of a paper or internet survey because 
parents of children that have been diagnosed with ASD are very busy and previous studies 
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performed by a consulting registered dietitian using paper or internet surveys showed low 
response rate. Please see appendix A-C for telephone and verbal consent scripts.  
Qualitative data was analyzed for central themes. Data was then summarized using 
descriptive statistics such as percentages and frequency counts. These data will be used for 
making further recommendations for nutrition interventions therapies for children with autism 
(NITA).  
 
Results 
Names and phone numbers of children who had a positive diagnosis for Autism 
Spectrum disorders, including classic autism, Asperger‟s Syndrome, and Persuasive 
Developmental Disability- Not Otherwise Specified (PDD-NOS) were obtained from 
three OSU clinics where these patients were seen over the past  1-25 months. Fifty-five 
(55) families were identified from the database and contacted by phone regarding 
biomedical interventions (the use of dietary and herbal supplements) explored and or 
employed since diagnosis. Of these  fifty-five,   21 were successfully interviewed, 2 
opted not to be interviewed, 20 were left messages and a researcher contact phone 
number, and 13 had disconnected lines.  
One participant decided not to disclose this information about her son so the 
following demographics are derived from the remaining  twenty (20) families. Twelve 
participants were diagnosed with Autism, 5 with PDD-NOS, 2 with PDD and 1 with 
Asperger‟s.  The age range of participants  was 2-8; 5 children were ages 2-3, 6 children 
ages 4-5, 6 children ages 6-7 and 2 children 8 years old or older.  Most of the families 
interviewed had a child diagnosed within the last year with the distribution as follows: 
diagnosed in the last 6 months- 7 children; children diagnosed within the 7-12 months - 
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8; diagnosed within 13-17 months, 2 children;    >18 or more months since diagnosis - 3 
children.  
Biomedical interventions are analyzed in this study as 2 separate categories, 
dietary supplements and special diets. Of the 21 families interviewed, 12 used 
supplements.  Eight families only used one supplement. Most of these eight families used 
multivitamin only (6), one used fish oil and one specifically stated they used Omega-3 
fatty acids. Four families used 2 or more supplements. The list of supplement use among 
these four families use was as follows: multivitamin(3), fish oil (3), probiotics(2), Folic 
Acid with B-12(1), Co-enzyme Q-10 (COQ 10)(1), B-2(1), Vitamin A(1), B12 topical 
cream(1), calcium with vitamin D(1), liquid calcium and magnesium(1), cod liver oil(1), 
vitamin and mineral powder(1), B-12 shots(1), chewable fiber (1), vitamin C (1). 
The study revealed that most of the parents interviewed had considered following 
a special diet or modifying diet in some way. About half the parents were currently 
considering diet change but had not implemented it (10). Eight parents interviewed were 
currently using diet special diet for an intervention. The Gluten- Free, Casein- Free diet 
was the most popular with 6 families that have tried special diets. Of those, 4 were still 
using the diet and the others have stopped due to its difficulty, the child‟s need to fit in 
socially,  or  lack of perceived effectiveness. The 2 other diets used were a low fat diet 
with the help of Bureau for Children with Medical Handicaps (BCMH), and the Helping 
Hands Education and Therapy Center diet (Figure 1). With the Helping Hands diet, a 
coordinator at this special school for autistic kids feeds the child a healthy breakfast and 
lunch and the mom feeds the child a healthy dinner. If the son eats something he doesn‟t 
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like, he is rewarded with a bite of something he does. The child of the family interviewed 
did not eat for two days but now eats a healthy diet. 
 
 
Figure 1-The Use of Special Diets by Children with Autism 
 
The families were asked about what sources they consulted to obtain information 
regarding biomedical interventions. “Sources sought”  were   classified in two separate 
categories: practitioners and non-practitioners (referred to as other sources for this study). 
Fifteen families consulted a practitioner about biomedical interventions. Of these, 3 
consulted a Registered Dietitian, 3 consulted a pediatrician, 4 consulted a 
nonconventional practitioner and 3 consulted an „other‟ practitioner (Figure 2).  Non 
conventional practitioners are comprised of  “ Defeat Autism Now” (DAN) doctors and a 
“ New Hope detoxification doctor”. „Other‟ practitioners‟ input sought found in this 
study were from that of  a food coach, a BCMH workshop and a Helping Hands case 
manager.  
13 
 
 
Figure 2- Allopathic and Alternative Practitioners 
Several non-practitioners, or other sources, were also used by families to  obtain 
information about biomedical treatments.  The Internet was the most popular non-
practitioner source sought (61%) followed by books, especially that by Jenny McCarthy: 
Healing and Preventing Autism: A Complete Guide.  Families also consulted other 
parents of children with ASD, friends, families, and teachers. While not cited directly as a 
source, Occupational Therapists seem to have an influence on treatments parents choose. 
Of the 7 families who sought alternative or „other‟ practitioners, 2 were recommended by 
the child‟s occupational therapist (the New Hope detoxification doctor and the food 
coach). Of the internet sites, autismspeaks.com was the most popular. See Table 1 for the 
distribution of parents who consulted these sources.  
\ 
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Other Sources Sought (N = 21)  Count(%) 
  Internet  13 (61.9%)  
  Books  7 (23.8%)  
  Jenny McCarthy‟s Book  5 (23.8%)  
  Other Parents of Children with ASD  4 (19%)  
  School and Teachers  3 (14.3%)  
  Observe Children with ASD  2 (9.5%)  
  Friends and Family  2 (9.5%) 
Table 1- Consultation of Other sources for Diet and Biomedical Treatments 
 
The number of supplements used by each family studied in terms of  months since 
diagnosis. Of the families with a child diagnosed in the last 6 months, 5.7% used 0 
supplements, 0% used 1 supplement and 43% used 2 or more. Of the families with a child 
diagnosed 7-12 months ago, 37.5% used 0 supplements, 37.5% used 1 supplement and 
25% used 2 or more.  Of the families with a child diagnosed in the past 13-18 months 
ago, 50% used 0 supplements, 50% used 1 supplement and 0% used 2 or more. Of the 
families with a child diagnosed more than 18 months ago, 66.6% used 0 supplements, 
33.3% used 1 supplement and 0% used 2 or more (Figure 3) 
15 
 
  
Figure 3-Prevalence of Supplement Use from Time of Diagnosis 
 
Discussion 
 
A previous study conducted by our team addressing biomedical interventions 
demonstrated that families used more supplements 2-5 years after diagnosis (Marschner, 
Geraghty, Guthrie, Rabidoux, Taylor). This contradiction may be due to the previous 
study‟s the use of an internet survey and how busy the families are with newly diagnosed 
child with ASD, rendering the population‟s completion of a lengthy survey nearly 
impossible. Receiving a phone call seemed to be a more convenient method of reaching 
parents with a child who has been diagnosed in the last 2 years. When studying the data 
regarding the number of supplements used in families with children diagnosed more than 
one year ago, it seems they use less supplements. However, the sample size of families 
with children diagnosed more than one year ago included only five participants. This is 
attributed to the large number of disconnected phones of families with a diagnosis more 
than one year ago. It is likely that families with children who have been diagnosed with 
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ASD move or change phone numbers more than the general population due to financial 
and other stresses.   
One limitation of this study was the small sample size. Future studies should be 
conducted with a larger sample. These studies could also be improved by asking parents 
how they perceive the biomedical treatments are working. Several parents mentioned the 
perceived effectiveness in the interviews; however this data was not captured in that it 
was not a component of the original study objectives.  
This data is clinically relevant in that demonstrated that parents are interested in 
biomedical treatments if their child has been diagnosed with ASD. It assists clinicians in 
realizing that it would be advisable to intervene shortly after diagnosis in order to reach 
families with evidence-based, sound information before they start their child on 
biomedical treatments. It is also clinically important for Occupational Therapists to 
understand their role in recommending treatments and practitioners. A clinician who is 
interested in educating parents should read Jenny McCarthy‟s book and browse internet 
sites such as Autismspeaks.com to become familiar with what information this population 
is consulting.  
 
Conclusion 
 
This study accomplished the goals of painting a broad picture of families who have 
had their child diagnosed in the last two years from the Ohio State University Nisonger 
diagnostic clinics. This picture will allow practitioners to better address the educational 
needs of a family with a child diagnosed with ASD.  Comparing the months since 
diagnosis to number of supplements used, showed that families use more supplements in 
17 
 
the first 6 months following diagnosis and fewer supplements at 18+ months (Figure 3). 
Therefore, education for parents about supplement use is important in the first 6 months 
after diagnosis since that is when supplement use is the highest. This study also 
demonstrated that families are consulting a variety of allopathic and alternative 
practitioners as well as the internet and popular books to obtain information regarding 
biomedical treatments. Non-conventional practitioners composed the largest group of 
practitioners consulted about biomedical interventions. This is critical for a clinician to 
note when treating a child with ASD since not all parents are receiving the same 
evidence-based scientific information addressing the safety and efficacy of the various 
treatments. In order to best serve the ASD population, clinicians should be aware of the 
information parents are receiving about potentially harmful biomedical interventions and 
the sources of this sometimes inaccurate information, involving potentially dangerous 
biomedical therapies. Educational Intervention plans in the Columbus area  include the 
development of Nutrition Interventions and Therapies for Autism  (NITA) workshops for 
both familes and practitioners by Dr. Maureen Geraghty and her students as a service to 
the ever-growing autism community.    
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Appendix A: Consent for Research 
 
Verbal Consent to Conduct Interview obtained using the following Script: 
 
 This interview will take anywhere from 2-20 minutes and your participation in the study 
is over when the interview ends. After this simple interview, my advisor Dr. Geraghty and I will 
analyze the data for descriptive trends. The only foreseeable risk of participation in this study is 
the slim possibility of “breach of confidentiality”. This risk is addressed because data will be 
stored in a locked drawer in a locked office where it is kept for three years then destroyed. Also 
identity is coded and only the principle investigator will have access to the sheet that links the 
codes to the identifying information. We are hoping this research will benefit the Autism 
community by providing data of the number of parents using biomedical treatments, the length of 
time between diagnosis and treatment use and how the parents become informed of these 
treatments. This will help clinics be aware if they need to have more professionals to consult with 
parents on these treatments. You may contact Jennifer Morgenstern at 317-850-6155 or Dr. 
Maureen Geraghty at 614-247-4595 if you have any pertinent questions about this study, the 
subject‟s rights or if you feel that there has been any research related harm. Your participation in 
this research is completely voluntary and refusal will not penalize you or your child in anyway. 
You may withdraw from this study at any time by calling the numbers given previously. 
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Appendix B: HIPAA Consent 
 
 
Consent to use information from database was obtained using the following script: 
 
We also need your permission to access some data from a database of Nisonger Diagnostic Team 
Clinic‟s patients. From that database we would like to look at diagnosis, date of diagnosis, age 
and gender. Only my advisor Dr. Geraghty and I will have access to these data if you consent We 
would like to compare diagnosis, date of diagnosis, age and gender to whether or not biomedical 
treatments are used to find any trends. Your child‟s PHI may be re-disclosed to the recipient and 
may no longer be protected by the privacy rule. Again, this is completely voluntary and you may 
withdraw without any negative consequences at any time. 
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Appendix C: Interview Script 
 
 
 
Intro: Hi, my name is Jen Morgenstern. I am an honors student in the health and wellness 
major at Ohio State University and am conducting a research study for a senior thesis. The 
purpose of this study is to gain information on parent‟s uses of biomedical, or biologically based 
treatments such as the gluten free-casein free diet, anti-fungals, and supplements of different 
vitamins including B-6 and 12, magnesium, and folic acid via a telephone interview. We are also 
interested in where parent‟s gained information on these treatments. If you are interested in taking 
part in this study, I would need to obtain a verbal consent from you. 
 
 
After consents are obtained, This is the script for the interview. 
 
Question 1: Once you received the diagnosis, did you consider any nutrition or dietary changes, 
for example special diets, herbal supplements or dietary supplements? 
 If the response is no: is there any reason that you came to that conclusion? 
 If the response is yes: have you used any supplements or special diets 
o If yes: which diets or supplements have you used? (If the parent does not 
provide a list on his or her own I will prompt with a list of special diets 
and supplements) 
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Question 2: What sources have you consulted about special diets, herbal or dietary supplements?  
 If the parent does not come up with a list on his or her own or if a parent only 
mentions one or two sources, a list of sources including friends and family, 
internet, workshops or health care professional will be used as a prompt 
o If internet: do you remember which sites were useful to you? 
o If health care professional: what kind of professional was it (nurse, 
doctor ,alternative practitioner, registered dietitian?) 
o If workshop: do you remember who sponsored the workshop? 
 
 
 
Thank you so much for your time, I really appreciate your help! 
 
 
 
 
 
 
 
 
